IDiyas

For the Inventor, By the Inventor

Winston-Salem, NC, United States of America

Balwinder Singh Bhatti

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 343(Granted Patents)


Location History:

  • Lexington, KY (US) (1997 - 1998)
  • Winstom-Salem, NC (US) (2020)
  • Winston-Salem, NC (US) (2000 - 2023)

Company Filing History:

goldMedal32 out of 91 
 
Targacept, Inc.
 patents
silverMedal4 out of 18 
 
Oyster Point Pharma, Inc.
 patents
bronzeMedal2 out of 26 
 
Catalyst Biosciences, Inc.
 patents
4. 1 out of 1 
 
Targaeept, Inc.
 patent
5. 4 out of 832,680 
Other
 patents

Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):Explore Patents
1. 11542253 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2023-01-03),
2. 10919879 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2021-02-16),
3. 10716770 - Nicotinic receptor non-competitive antagonists (2020-07-21),
4. 10421745 - Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2019-09-24),
5. 10258582 - Nicotinic receptor non-competitive antagonists (2019-04-16),
6. 9981949 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine (2018-05-29),
7. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),
8. 9145396 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine (2015-09-29),
9. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),
10. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),
11. 8604191 - Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3YLVINYL)pyrimidine (2013-12-10),
12. 8288420 - Compounds capable of activating cholinergic receptors (2012-10-16),
13. 8153821 - Compounds (2012-04-10),
14. 7923559 - N-aryl diazaspirocyclic compounds and methods of preparation and use thereof (2011-04-12),
15. 7897611 - Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders (2011-03-01),

Title: **Balwinder Singh Bhatti: Innovator in Pharmaceutical Science**

Introduction

Balwinder Singh Bhatti is a prominent inventor based in Winston-Salem, NC, with an impressive portfolio of 43 patents. His work primarily focuses on the synthesis of novel chemical compounds, contributing significantly to the pharmaceutical industry.

Latest Patents

Among his latest contributions are patents related to the synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine. This invention details the stereospecific synthesis of this compound, along with its salt forms and novel polymorphic forms of these salts. The implications of such inventions are considerable, enhancing the development of new therapeutic agents.

Career Highlights

Bhatti has had a successful career working with notable companies, including Targacept, Inc. His expertise in chemical synthesis and pharmaceutical formulations has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Bhatti has collaborated with industry experts such as Gary Maurice Dull and Craig Harrison Miller. These partnerships have likely contributed to the breadth of his innovative work and patent portfolio.

Conclusion

Balwinder Singh Bhatti continues to make significant strides in the realm of pharmaceutical sciences. His commitment to innovation and the successful synthesis of complex compounds plays a vital role in advancing medical solutions. His numerous patents not only showcase his inventive spirit but also reflect the impact of his work on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…